Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Open in API
Filings indexed 1,484 across all filing types
Latest filing 2023-06-05 Director's Dealing
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 1 June 2023.
Director's Dealing Classification · 100% confidence The document explicitly states it is a 'NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014'. It details transactions (specifically a 'Pledge of shares') executed by an entity related to a key person ('Ognian Donev') concerning the Company's shares. This directly matches the definition for Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The short length (860 chars) confirms it is a notification, not the full regulatory form.
2023-06-05 English
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 1 June 2023.
Director's Dealing Classification · 100% confidence The document explicitly states it is a 'NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014'. It details transactions executed by an entity related to a director ('Ognian Donev') involving company warrants. This directly corresponds to the definition of Director's Dealing (insider trades) provided by the filing definitions, which is coded as DIRS.
2023-06-05 English
Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 1 June 2023.
Director's Dealing Classification · 100% confidence The document is explicitly titled 'NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014'. It details transactions (Sell operations) executed by an insider ('Vesela Stoeva' via 'Telso' AD) involving the company's shares. This directly corresponds to the definition of Director's Dealing (insider trades).
2023-06-05 English
Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 1 June 2023.
Director's Dealing Classification · 100% confidence The document explicitly states it is a "NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". It details transactions (Sell) executed by an entity ("Telso" AD) related to an individual associated with the company ("Vesela Stoeva") concerning warrants. This directly corresponds to the definition of Director's Dealing (insider trades by directors/executives). The appropriate code is DIRS.
2023-06-05 English
Minutes of the Annual General Meeting of Shareholders of Sopharma AD, held on 2 June 2023 from 11:00 a.m. (UTC 8:00 a.m.)
AGM Information Classification · 19% confidence
2023-06-02 Polish
Notification on the terms and conditions for distribution of the dividend
AGM Information Classification · 99% confidence The document is a 'Current report' dated June 2, 2023, specifically notifying shareholders about a decision made at the Annual General Meeting (AGM) regarding the distribution of a gross dividend of 0.60 BGN per share. It details the record date (June 16, 2023) and payment mechanism. Since the core subject is the announcement of the dividend amount and terms, this directly corresponds to the 'Notice of Dividend Amount' definition (DIV). Although it references the AGM, the primary action being reported is the dividend declaration, not the AGM proceedings (AGM-R) or the voting results (DVA). The document length is short (1260 chars), but its content is a specific financial action announcement, making DIV the most precise fit over a general RPA or RNS.
2023-06-02 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.